U.S. regulators should reject a proposed weight-loss pill called Zimulti because of concerns it may increase suicidal thinking and depression, an advisory panel unanimously said on Wednesday.
From: news.yahoo.com
U.S. panel rejects Sanofi obesity drug
Posted by Ruslan Abuzant at 7:56 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment